Ethema Health Corp
OTC:GRST
Ethema Health Corp
OTC:GRST
Price:
0.0001
USD
-50%
Market Closed
Market Cap:
$772.6k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ethema Health Corp
OTC:GRST
|
US |
|
Worldline SA
OTC:WWLNF
|
FR |
|
Knorr Bremse AG
XETRA:KBX
|
DE |
|
S
|
SPEL Semiconductor Ltd
BSE:517166
|
IN |
|
Peninsula Land Ltd
NSE:PENINLAND
|
IN |
|
S
|
Supermax Corporation Bhd
KLSE:SUPERMX
|
MY |
Balance Sheet
Balance Sheet Decomposition
Ethema Health Corp
Ethema Health Corp
Balance Sheet Decomposition is not available for
Ethema Health Corp
Ethema Health Corp
Balance Sheet
Ethema Health Corp
Ethema Health Corp
Currency: USD
| Dec-1999 | Dec-2000 | Dec-2001 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
3
|
2
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
|
| PP&E Net |
3
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
3
|
3
|
5
|
4
|
10
|
11
|
|
| PP&E Gross |
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
10
|
11
|
|
| Accumulated Depreciation |
0
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
7
+16%
|
5
-24%
|
1
-81%
|
1
+20%
|
1
+6%
|
1
-4%
|
0
-75%
|
0
+59%
|
12
+2 567%
|
13
+3%
|
3
-75%
|
4
+19%
|
7
+71%
|
7
+0%
|
12
+76%
|
12
+6%
|
|
| Liabilities | ||||||||||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
3
|
2
|
1
|
0
|
0
|
0
|
3
|
7
|
8
|
7
|
8
|
8
|
5
|
7
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
2
|
3
|
3
|
2
|
3
|
4
|
5
|
9
|
6
|
1
|
1
|
3
|
2
|
|
| Total Current Liabilities |
1
|
0
|
1
|
4
|
4
|
4
|
4
|
3
|
4
|
7
|
14
|
19
|
14
|
14
|
13
|
8
|
10
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
5
|
5
|
1
|
1
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
10
|
|
| Total Liabilities |
2
N/A
|
0
-80%
|
1
+23%
|
4
+619%
|
4
+12%
|
4
-2%
|
4
-9%
|
3
-12%
|
4
+6%
|
14
+286%
|
20
+45%
|
23
+14%
|
19
-18%
|
17
-12%
|
16
-3%
|
18
+9%
|
20
+11%
|
|
| Equity | ||||||||||||||||||
| Common Stock |
3
|
3
|
27
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
21
|
36
|
38
|
37
|
77
|
|
| Retained Earnings |
0
|
3
|
3
|
9
|
14
|
18
|
20
|
21
|
21
|
22
|
31
|
45
|
42
|
44
|
43
|
42
|
44
|
|
| Additional Paid In Capital |
0
|
0
|
19
|
6
|
10
|
14
|
16
|
16
|
17
|
19
|
21
|
23
|
23
|
23
|
23
|
26
|
25
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
17
|
25
|
27
|
27
|
65
|
|
| Total Equity |
3
N/A
|
6
+76%
|
4
-27%
|
3
N/A
|
3
-9%
|
3
+4%
|
3
+11%
|
3
-15%
|
3
-2%
|
2
+44%
|
8
-334%
|
20
-159%
|
15
+23%
|
10
+33%
|
10
+6%
|
6
+36%
|
7
-20%
|
|
| Total Liabilities & Equity |
6
N/A
|
7
+16%
|
5
-24%
|
1
-81%
|
1
+20%
|
1
+6%
|
1
-4%
|
0
-75%
|
0
+59%
|
12
+2 567%
|
13
+3%
|
3
-75%
|
4
+19%
|
7
+71%
|
7
+0%
|
12
+76%
|
12
+6%
|
|
| Shares Outstanding | ||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
27
|
27
|
41
|
46
|
48
|
49
|
123
|
124
|
155
|
2 207
|
3 579
|
3 729
|
3 729
|
7 729
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
4
|
4
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
